
Thurman Michael Wheeler
Examiner (ID: 7797)
| Most Active Art Unit | 1619 |
| Art Unit(s) | 1619 |
| Total Applications | 720 |
| Issued Applications | 281 |
| Pending Applications | 73 |
| Abandoned Applications | 382 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 19141988
[patent_doc_number] => 20240140809
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2024-05-02
[patent_title] => COMPOSITE SOLS
[patent_app_type] => utility
[patent_app_number] => 18/207289
[patent_app_country] => US
[patent_app_date] => 2023-06-08
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 11285
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -23
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18207289
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/207289 | COMPOSITE SOLS | Jun 7, 2023 | Abandoned |
Array
(
[id] => 19048529
[patent_doc_number] => 20240090498
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2024-03-21
[patent_title] => ANTIMICROBIAL COMPOSITIONS
[patent_app_type] => utility
[patent_app_number] => 18/309894
[patent_app_country] => US
[patent_app_date] => 2023-05-01
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 4504
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -7
[patent_words_short_claim] => 54
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18309894
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/309894 | ANTIMICROBIAL COMPOSITIONS | Apr 30, 2023 | Pending |
Array
(
[id] => 18807083
[patent_doc_number] => 20230381416
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-11-30
[patent_title] => MEDICAL DEVICE CONTAINING A CAKE COMPOSITION COMPRISING ARIPIPRAZOLE AS AN ACTIVE INGREDIENT, AND A CAKE COMPOSITION COMPRISING ARIPIPRAZOLE AS AN ACTIVE INGREDIENT.
[patent_app_type] => utility
[patent_app_number] => 18/297683
[patent_app_country] => US
[patent_app_date] => 2023-04-10
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 12199
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -20
[patent_words_short_claim] => 19
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18297683
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/297683 | MEDICAL DEVICE CONTAINING A CAKE COMPOSITION COMPRISING ARIPIPRAZOLE AS AN ACTIVE INGREDIENT, AND A CAKE COMPOSITION COMPRISING ARIPIPRAZOLE AS AN ACTIVE INGREDIENT. | Apr 9, 2023 | Abandoned |
Array
(
[id] => 18496229
[patent_doc_number] => 20230218796
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-07-13
[patent_title] => Tissue adhesive for use in a treatment method in which an ophthalmological implant is implanted in a human or animal patient, and ophthalmological implantation system
[patent_app_type] => utility
[patent_app_number] => 18/185191
[patent_app_country] => US
[patent_app_date] => 2023-03-16
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 5063
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -17
[patent_words_short_claim] => 85
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18185191
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/185191 | Tissue adhesive for use in a treatment method in which an ophthalmological implant is implanted in a human or animal patient, and ophthalmological implantation system | Mar 15, 2023 | Pending |
Array
(
[id] => 18374240
[patent_doc_number] => 20230149317
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-05-18
[patent_title] => COMPOSITION FOR PROMOTING WOUND HEALING
[patent_app_type] => utility
[patent_app_number] => 18/151402
[patent_app_country] => US
[patent_app_date] => 2023-01-06
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 4424
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -6
[patent_words_short_claim] => 41
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18151402
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/151402 | Composition for promoting wound healing | Jan 5, 2023 | Issued |
Array
(
[id] => 18611088
[patent_doc_number] => 20230277818
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-09-07
[patent_title] => DRUG RELEASING COATINGS FOR BALLOON CATHETERS
[patent_app_type] => utility
[patent_app_number] => 18/093171
[patent_app_country] => US
[patent_app_date] => 2023-01-04
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 9888
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -18
[patent_words_short_claim] => 207
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18093171
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/093171 | DRUG RELEASING COATINGS FOR BALLOON CATHETERS | Jan 3, 2023 | Abandoned |
Array
(
[id] => 18404527
[patent_doc_number] => 20230165878
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-06-01
[patent_title] => PHARMACEUTICAL DELIVERY SYSTEMS FOR HYDROPHOBIC DRUGS AND COMPOSITIONS COMPRISING SAME
[patent_app_type] => utility
[patent_app_number] => 17/992634
[patent_app_country] => US
[patent_app_date] => 2022-11-22
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 9705
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -6
[patent_words_short_claim] => 102
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17992634
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/992634 | PHARMACEUTICAL DELIVERY SYSTEMS FOR HYDROPHOBIC DRUGS AND COMPOSITIONS COMPRISING SAME | Nov 21, 2022 | Abandoned |
Array
(
[id] => 18310505
[patent_doc_number] => 20230114405
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-04-13
[patent_title] => Microemulsion Delivery Systems for A Female Hormone Blend with Alcohol-Soluble Species Including Nonderivatized Hormones
[patent_app_type] => utility
[patent_app_number] => 17/967267
[patent_app_country] => US
[patent_app_date] => 2022-10-17
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 10530
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -49
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17967267
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/967267 | Microemulsion Delivery Systems for A Female Hormone Blend with Alcohol-Soluble Species Including Nonderivatized Hormones | Oct 16, 2022 | Pending |
Array
(
[id] => 18312142
[patent_doc_number] => 20230116042
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-04-13
[patent_title] => ADJUVANT FORMULATIONS COMPRISING TLR4 AGONISTS AND METHODS OF USING THE SAME
[patent_app_type] => utility
[patent_app_number] => 17/960110
[patent_app_country] => US
[patent_app_date] => 2022-10-04
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 23419
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -19
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17960110
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/960110 | ADJUVANT FORMULATIONS COMPRISING TLR4 AGONISTS AND METHODS OF USING THE SAME | Oct 3, 2022 | Abandoned |
Array
(
[id] => 18312909
[patent_doc_number] => 20230116809
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-04-13
[patent_title] => PREVENTION AND TREATMENT OF OCULAR CONDITIONS
[patent_app_type] => utility
[patent_app_number] => 17/937564
[patent_app_country] => US
[patent_app_date] => 2022-10-03
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 32407
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -27
[patent_words_short_claim] => 37
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17937564
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/937564 | PREVENTION AND TREATMENT OF OCULAR CONDITIONS | Oct 2, 2022 | Abandoned |
Array
(
[id] => 18268996
[patent_doc_number] => 20230090238
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-03-23
[patent_title] => COMPOSITIONS, METHODS, SYSTEMS AND KITS FOR THE TREATMENT OF NOSEBLEEDS
[patent_app_type] => utility
[patent_app_number] => 17/946556
[patent_app_country] => US
[patent_app_date] => 2022-09-16
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 7827
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -17
[patent_words_short_claim] => 39
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17946556
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/946556 | COMPOSITIONS, METHODS, SYSTEMS AND KITS FOR THE TREATMENT OF NOSEBLEEDS | Sep 15, 2022 | Pending |
Array
(
[id] => 18595878
[patent_doc_number] => 20230270667
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-08-31
[patent_title] => CANNABIDIOL INFUSED CANDLE
[patent_app_type] => utility
[patent_app_number] => 17/822198
[patent_app_country] => US
[patent_app_date] => 2022-08-25
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 1409
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -5
[patent_words_short_claim] => 35
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17822198
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/822198 | CANNABIDIOL INFUSED CANDLE | Aug 24, 2022 | Abandoned |
Array
(
[id] => 18077332
[patent_doc_number] => 20220402944
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-12-22
[patent_title] => Functionalized Mesoporous Silica via an Aminosilane Surfactant Ion Exchange Reaction: Controlled Scaffold Design and Nitric Oxide Release
[patent_app_type] => utility
[patent_app_number] => 17/821371
[patent_app_country] => US
[patent_app_date] => 2022-08-22
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 8868
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -18
[patent_words_short_claim] => 14
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17821371
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/821371 | Functionalized Mesoporous Silica via an Aminosilane Surfactant Ion Exchange Reaction: Controlled Scaffold Design and Nitric Oxide Release | Aug 21, 2022 | Pending |
Array
(
[id] => 19681686
[patent_doc_number] => 20250000231
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2025-01-02
[patent_title] => ARTIFICIAL NAIL FOR USE IN THE TREATMENT OF A NAIL DISEASE
[patent_app_type] => utility
[patent_app_number] => 18/292174
[patent_app_country] => US
[patent_app_date] => 2022-08-04
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 7433
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -19
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18292174
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/292174 | ARTIFICIAL NAIL FOR USE IN THE TREATMENT OF A NAIL DISEASE | Aug 3, 2022 | Pending |
Array
(
[id] => 18295477
[patent_doc_number] => 20230105163
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-04-06
[patent_title] => ORAL TESTOSTERONE ESTER FORMULATIONS AND METHODS OF TREATING TESTOSTERONE DEFICIENCY COMPRISING SAME
[patent_app_type] => utility
[patent_app_number] => 17/814296
[patent_app_country] => US
[patent_app_date] => 2022-07-22
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 11073
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -14
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17814296
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/814296 | ORAL TESTOSTERONE ESTER FORMULATIONS AND METHODS OF TREATING TESTOSTERONE DEFICIENCY COMPRISING SAME | Jul 21, 2022 | Pending |
Array
(
[id] => 18075733
[patent_doc_number] => 20220401345
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-12-22
[patent_title] => POLYMER-BASED ANTIMICROBIAL COMPOSITIONS AND METHODS OF USE THEREOF
[patent_app_type] => utility
[patent_app_number] => 17/869477
[patent_app_country] => US
[patent_app_date] => 2022-07-20
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 24534
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -9
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17869477
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/869477 | POLYMER-BASED ANTIMICROBIAL COMPOSITIONS AND METHODS OF USE THEREOF | Jul 19, 2022 | Pending |
Array
(
[id] => 20452969
[patent_doc_number] => 12516019
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2026-01-06
[patent_title] => Amphoteric compounds
[patent_app_type] => utility
[patent_app_number] => 17/864827
[patent_app_country] => US
[patent_app_date] => 2022-07-14
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 8779
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 159
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17864827
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/864827 | Amphoteric compounds | Jul 13, 2022 | Issued |
Array
(
[id] => 18258452
[patent_doc_number] => 20230085492
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-03-16
[patent_title] => SHEAR-THINNING COMPOSITIONS AS AN INTRAVASCULAR EMBOLIC AGENT
[patent_app_type] => utility
[patent_app_number] => 17/862959
[patent_app_country] => US
[patent_app_date] => 2022-07-12
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 20171
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -17
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17862959
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/862959 | SHEAR-THINNING COMPOSITIONS AS AN INTRAVASCULAR EMBOLIC AGENT | Jul 11, 2022 | Pending |
Array
(
[id] => 18107935
[patent_doc_number] => 20230000815
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-01-05
[patent_title] => Acid-Labile Chemotherapeutic Compounds and Compositions
[patent_app_type] => utility
[patent_app_number] => 17/840455
[patent_app_country] => US
[patent_app_date] => 2022-06-14
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 13451
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -15
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17840455
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/840455 | Acid-Labile Chemotherapeutic Compounds and Compositions | Jun 13, 2022 | Abandoned |
Array
(
[id] => 19379470
[patent_doc_number] => 20240269340
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2024-08-15
[patent_title] => MICROSPHERES WITH FLOW THROUGH VOIDS AS EMBOLIC AND DRUG DELIVERY AGENTS
[patent_app_type] => utility
[patent_app_number] => 18/569332
[patent_app_country] => US
[patent_app_date] => 2022-06-12
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 13040
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -19
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18569332
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/569332 | MICROSPHERES WITH FLOW THROUGH VOIDS AS EMBOLIC AND DRUG DELIVERY AGENTS | Jun 11, 2022 | Pending |